Filing Details
- Accession Number:
- 0001013762-10-001262
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-21 13:00:00
- Reporting Period:
- 2010-05-20
- Filing Date:
- 2010-05-21
- Accepted Time:
- 2010-05-21 12:40:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1140098 | Advanced Cell Technology Inc. | ACTC | Pharmaceutical Preparations (2834) | 870656515 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317093 | Robert Lanza | 381 Plantation Street Worchester MA 01605 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Disposition | 2010-05-20 | 600,000 | $0.07 | 29,153,180 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
